Drug Profile
Research programme: asthma therapies - Selecore
Alternative Names: Tryptase inhibitors - SelecoreLatest Information Update: 18 May 2011
Price :
$50
*
At a glance
- Originator Selecore
- Class Proteins
- Mechanism of Action Tryptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 07 Sep 2005 Preclinical trials in Asthma in Germany (unspecified route)